• HOME
  • ABOUT
  • LEUKEMIA
  • CANCER
  • NEUROSCIENCE
  • MEDICAL DISTRIBUTION
    • Medical
  • COVID-19
    • COVID-19 Tests
    • COVID-19 Home Tests
    • COVID-19 Antigen Tests
    • FDA/Legal Disclaimer
  • News & Press articles
  • Medical Blog
  • Infectious Diseases
  • Research
    • Video Demonstration
    • Alercell Research
    • Corporate Presentation
  • Contact
  • Careers
  • More
    • HOME
    • ABOUT
    • LEUKEMIA
    • CANCER
    • NEUROSCIENCE
    • MEDICAL DISTRIBUTION
      • Medical
    • COVID-19
      • COVID-19 Tests
      • COVID-19 Home Tests
      • COVID-19 Antigen Tests
      • FDA/Legal Disclaimer
    • News & Press articles
    • Medical Blog
    • Infectious Diseases
    • Research
      • Video Demonstration
      • Alercell Research
      • Corporate Presentation
    • Contact
    • Careers
  • HOME
  • ABOUT
  • LEUKEMIA
  • CANCER
  • NEUROSCIENCE
  • MEDICAL DISTRIBUTION
    • Medical
  • COVID-19
    • COVID-19 Tests
    • COVID-19 Home Tests
    • COVID-19 Antigen Tests
    • FDA/Legal Disclaimer
  • News & Press articles
  • Medical Blog
  • Infectious Diseases
  • Research
    • Video Demonstration
    • Alercell Research
    • Corporate Presentation
  • Contact
  • Careers

Legal Disclaimers

These tests have not been reviewed by the FDA, however the Tests have an EUA authorization form the FDA.


Negative results do not preclude acute SARS-CoV-2 infection. If acute infection is suspected, direct testing for SARS-CoV-2 is necessary.

Results from antibody testing should not be used to diagnose or exclude acute SARS-CoV-2 infection.

 

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. 

All Tests sold by Alercell comply with the FDA labeling requirements under FDA regulations: 


Intended use statement (21 CFR 809.10(a)(2), (b)(2)); adequate directions for use (21 U.S.C. 352(f)), (21 CFR 809.10(b)(5), (7), and (8)); appropriate limitations on the use of the device including information required under 21 CFR 809.10(a)(4); an

All Tests sold by Alercell comply with the FDA labeling requirements under FDA regulations: 


Intended use statement (21 CFR 809.10(a)(2), (b)(2)); adequate directions for use (21 U.S.C. 352(f)), (21 CFR 809.10(b)(5), (7), and (8)); appropriate limitations on the use of the device including information required under 21 CFR 809.10(a)(4); and any available information regarding performance of the device, including requirements under 21 CFR 809.10(b)(12).

FDA on testing process

Download PDF

Copyright © 2020 Alercell - All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept